[Skip to Navigation]
Sign In

August 2021 - April 2016

Decade

Year

Issue

September 2020, Vol 5, No. 9, Pages 977-1071

Original Investigation

Echocardiographic Characterization of Female Professional Basketball Players in the US

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):991-998. doi:10.1001/jamacardio.2020.0988

This cross-sectional study assesses cardiac structure and function in elite female basketball players.

Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse

Abstract Full Text
free access has audio
JAMA Cardiol. 2020;5(9):1000-1005. doi:10.1001/jamacardio.2020.1555

This study characterizes the burden and distribution of fluorine 18–labeled fluorodeoxyglucose uptake and late gadolinium enhancement in patients with degenerative mitral valve prolapse and ventricular ectopy.

Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1006-1010. doi:10.1001/jamacardio.2020.1725

This study describes the current geographic access to transcatheter aortic replacement centers in the United States.

Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors

Abstract Full Text
free access has audio
JAMA Cardiol. 2020;5(9):1011-1018. doi:10.1001/jamacardio.2020.1731

This cohort study examines the association of systolic blood pressure levels with the risk of atherosclerotic cardiovascular disease in persons without atherosclerotic cardiovascular disease risk factors.

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1020-1026. doi:10.1001/jamacardio.2020.1855

This cohort study assesses the association between use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with the likelihood of testing positive for coronavirus disease 2019 (COVID-19).

Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1027-1035. doi:10.1001/jamacardio.2020.2081

This cohort study evaluates whether risk of clinical events experienced by patients with heart failure with midrange ejection fraction varies according to whether left ventricular ejection fraction improved or deteriorated into the range of 40% to 50% from previous measurements.

Brief Report

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2020;5(9):1036-1041. doi:10.1001/jamacardio.2020.1834

This cohort study examines the association of hydroxychloroquine or hydroxychloroquine and azithromycin with QT prolongation in adult patients hospitalized with coronavirus disease 2019.

Trends in Readmission and Mortality Rates Following Heart Failure Hospitalization in the Veterans Affairs Health Care System From 2007 to 2017

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1042-1047. doi:10.1001/jamacardio.2020.2028

This cohort study evaluates trends in readmission and mortality after heart failure admission in the Veterans Affairs Health Care System, which had no financial penalties, from 2007 to 2017.

Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) Pandemic

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2020;5(9):1048-1052. doi:10.1001/jamacardio.2020.2696

This cross-sectional study describes national and regional trends in waitlist inactivations, waitlist additions, donor recovery, and heart transplant volume during the coronavirus disease 2019 (COVID-19) pandemic.

Research Letter

Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in History

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1066-1067. doi:10.1001/jamacardio.2020.1738

This economic evaluation study examines the authors’ experience of prescribing tafamidis in terms of their cost and the insurance status of patients.

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2020;5(9):1067-1069. doi:10.1001/jamacardio.2020.1787

This case series assesses QT intervals for French patients with coronavirus disease 2019 (COVID-19) treated with hydroxychloroquine alone or in combination with azithromycin.

Viewpoint

The Way Forward in Congenital Heart Disease Research

Abstract Full Text
JAMA Cardiol. 2020;5(9):979-980. doi:10.1001/jamacardio.2020.2034

This Viewpoint discusses the challenges facing congenital heart disease (CHD) research and proposes new approaches to designing successful clinical trials involving adults with CHD.

Fear of Coronavirus Disease 2019—An Emerging Cardiac Risk

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2020;5(9):981-982. doi:10.1001/jamacardio.2020.2890

This Viewpoint describes fear of coronavirus disease 2019 as an issue stopping patients from accessing needed cardiac care and methods to ameliorate negative outcomes.

From the Heart

On the Frontlines of the Coronavirus Disease 2019 (COVID-19) Crisis—The Many Faces of Leadership

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2020;5(9):983-984. doi:10.1001/jamacardio.2020.2240

This essay describes the author’s observations of the qualities developed by hospital staff members during the coronavirus disease 2019 (COVID-19) pandemic.

Life and Death, Hope and Despair in the Era of Coronavirus Disease 2019

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):985. doi:10.1001/jamacardio.2020.2420

This article presents the response of a physician to the fear and despair associated with coronavirus disease 2019.

Editorial

Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2020;5(9):986-987. doi:10.1001/jamacardio.2020.1782

Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19)

Abstract Full Text
JAMA Cardiol. 2020;5(9):988-990. doi:10.1001/jamacardio.2020.1874
Invited Commentary

Cardiac Data From the Women’s National Basketball Association—Caring for Women Requires Studying Women

Abstract Full Text
JAMA Cardiol. 2020;5(9):998-999. doi:10.1001/jamacardio.2020.2156

What Is a Normal Blood Pressure?

Abstract Full Text
has audio
JAMA Cardiol. 2020;5(9):1018-1019. doi:10.1001/jamacardio.2020.1742
Review

Association Between Malignant Mitral Valve Prolapse and Sudden Cardiac Death: A Review

Abstract Full Text
has active quiz has audio
JAMA Cardiol. 2020;5(9):1053-1061. doi:10.1001/jamacardio.2020.1412

This narrative review analyzes the clinical, electrocardiographic, imaging, and biological markers of sudden cardiac death in patients with mitral valve prolapse.

JAMA Cardiology Clinical Challenge

Dysphagia and Dyspnea in a Middle-aged Woman

Abstract Full Text
has active quiz
JAMA Cardiol. 2020;5(9):1063-1064. doi:10.1001/jamacardio.2020.2677

A woman in her early 60s presents with progressive dysphagia to solid foods for 2 years, new-onset dyspnea associated with cough and fever for 1 week, and poorly controlled hypertension for 10 years. What would you do next?

Cardiovascular Images

A Woman in Her 40s With Dilated Cardiomyopathy and Abdominal Contractions

Abstract Full Text
has multimedia
JAMA Cardiol. 2020;5(9):1062. doi:10.1001/jamacardio.2020.2563

This case reports describes a woman with severe heart failure who experienced diaphragmatic twitching after placement of a cardiac resynchronization therapy device.

A Middle-aged Patient in a Coma 4 Weeks After Percutaneous Radiofrequency Ablation for Atrial Fibrillation

Abstract Full Text
online only
JAMA Cardiol. 2020;5(9):e204138. doi:10.1001/jamacardio.2020.4138

This case report describes a rare complication of radiofrequency ablation for atrial fibrillation, with a fatal outcome.

Comment & Response

Myocardial Injury in COVID-19—Can We Successfully Target Inflammation?

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1069-1070. doi:10.1001/jamacardio.2020.2569

Myocardial Injury in COVID-19—Can We Successfully Target Inflammation?—Reply

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1070-1071. doi:10.1001/jamacardio.2020.2572
Correction

Errors in Abstract, Results, and End Matter

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1071. doi:10.1001/jamacardio.2020.2302

Errors in Table 2

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1071. doi:10.1001/jamacardio.2020.3183

Error in Text

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):1071. doi:10.1001/jamacardio.2020.3472
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2020;5(9):977. doi:10.1001/jamacardio.2019.3475
×